Dr. Victoria Yvonne Bird, MD, is a distinguished urologist, clinical innovator, and researcher specializing in prostate cancer diagnosis and treatment, with a particular focus on advanced imaging and minimally invasive therapies. She serves as CEO of UIC and held academic appointments including Faculty at the University of Florida, Department of Biomedical Engineering, College of Engineering and Assistant Professor of Urology at the University of Florida. Dr. Bird has developed a reputation as a leader in prostate cancer care through her integration of cutting-edge technologies such as MRI-guided interventions and ultrasound-MRI fusion platforms. Her clinical work emphasizes precision medicine, leveraging advanced imaging modalities to improve lesion detection, biopsy accuracy, and focal therapy planning. Dr. Bird is widely recognized for her pioneering contributions to the application of artificial intelligence (AI) in prostate cancer. Her work focuses on integrating AI algorithms with multiparametric MRI and ultrasound imaging to enhance diagnostic accuracy, automate prostate segmentation, and improve treatment targeting. She has contributed to the development and evaluation of AI-driven platforms capable of lesion detection, predictive modeling, and real-time image analysis, demonstrating performance comparable to or exceeding human interpretation in selected settings. Her research spans AI-assisted imaging, MRI-ultrasound fusion biopsy, and MRI-guided ablative therapies, positioning her at the forefront of innovation in urologic oncology. In addition to her clinical and research accomplishments, Dr. Bird is an active contributor to the scientific community through numerous publications and invited presentations at national and international conferences. She has presented extensively on topics including quantitative MRI, AI-driven imaging analytics, and image-guided treatment of prostate cancer, including participation in major forums such as the American Urological Association and global prostate cancer summits. Her work continues to shape the evolving landscape of precision urology, advancing the integration of artificial intelligence and advanced imaging to improve patient outcomes while minimizing treatment-related morbidity.